Tensive S.r.l. is a clinical-stage advanced biomaterials medical device company developing bioresorbable polymeric scaffolds for breast reconstruction and tissue marking. The company's patented REGENERA™ biomimetic scaffold is designed to allow regeneration of a patient's own breast tissue to create natural, safe, and lasting reconstruction for patients recovering from lumpectomy. The SOFTAG™ precision tissue marking device is designed to enable more targeted delivery of radiotherapy and increases the accuracy of surveillance and follow-up.
Tensive was founded in 2012 and is headquartered in Milan (Milano), Italy. The company has 11-50 employees and operates in the Medical Equipment Manufacturing industry. Tensive has raised €14M in a Series A financing round for its bio-absorbable breast implant, REGENERA, with funds supporting a pivotal clinical trial to assess the safety and performance of the implant.
Recent Leadership News
On July 8, 2026, Tensive appointed Peter Crosby as Chairman of its Board of Directors. Mr. Crosby brings more than 40 years of leadership in the medical technology and life sciences sectors, having served as chief executive of six medical device companies in four countries. Mr. Crosby succeeds Bill Hunter, MD, who was the chairman of the company for the past two years.
This is an automatically generated Light company page created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.
Facts compiled by Executive Moves from publicly available news and press releases on 8 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the Tensive S.r.l. team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
